![Allison Hulme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allison Hulme
Directeur Général chez
Aeovian Pharmaceuticals, Inc.
Profil
Dr. Allison J.
Hulme is a President, Chief Executive Officer & Director at Aeovian Pharmaceuticals, Inc. She is on the Board of Directors at Aeovian Pharmaceuticals, Inc. and InteKrin Therapeutics, Inc. Dr. Hulme was previously employed as an Independent Director by Ventyx Biosciences, Inc., an Executive Vice President & Head-Global Development by Elan Corp.
Plc, an Executive Vice President & Head-Global Development by Elan Pharmaceuticals, Inc., and a Principal by Glaxo Wellcome Plc.
She also served on the board at Sophiris Bio, Inc. She received her undergraduate degree from the University of Luton and a doctorate degree from Cranfield University.
Postes actifs de Allison Hulme
| Sociétés | Poste | Début |
|---|---|---|
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Directeur/Membre du Conseil | 01/01/2013 |
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Directeur Général | 01/01/2020 |
Anciens postes connus de Allison Hulme
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Directeur/Membre du Conseil | 04/03/2026 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01/10/2009 |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2005 |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| SOPHIRIS BIO | Directeur Technique/Scientifique/R&D | 31/12/2019 |
Formation de Allison Hulme
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Cranfield University
 Cranfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Luton
 University of Luton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Choisissez Zonebourse 
